SEQURNA AB
559398-6127ActiveDevelops thermostable RNase inhibitors for advanced RNA sequencing workflows.
Biotechnology Companysequrna.com
Yleiskatsaus
- 1–4
- Työntekijät
- 2.5–5milj SEK
- Liikevaihto
- 2022
- Perustettu
Avainpäättäjät
Antonio Lentini
Lead Computational Research & Development Specialist, and Co-founder
Joyce Noble
Lead Research & Development Specialist and Co-founder
Fredrik Olsson
Chairman of the Board
Björn Reinius
CEO and Co-founder
+4 lisää yhteystietoja Funnelfeedrissä
Kuvaus
SEQURNA is a biotechnology company specializing in innovative reagents for molecular biology research. Their flagship product is the SEQURNA® Thermostable RNase Inhibitor, designed to revolutionize RNA-sequencing workflows. Unlike traditional protein-based inhibitors, this synthetic compound maintai...